Terms: = Leukemia AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
2603 results:
1. Identification of triciribine as a novel myeloid cell differentiation inducer.
Suzuki S; Suzuki S; Sato-Nagaoka Y; Ito C; Takahashi S
PLoS One; 2024; 19(5):e0303428. PubMed ID: 38743735
[TBL] [Abstract] [Full Text] [Related]
2. Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity.
Moustafa AH; AboulMagd AM; Ali AM; Khodairy A; Marzouk AA; Nafady A; T M Nemr M
Bioorg Chem; 2024 Jun; 147():107410. PubMed ID: 38688197
[TBL] [Abstract] [Full Text] [Related]
3. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract] [Full Text] [Related]
4. Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis.
Qiu Y; Bai L; Zhao H; Mei X
BMC Cancer; 2024 Apr; 24(1):520. PubMed ID: 38658865
[TBL] [Abstract] [Full Text] [Related]
5. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/erk and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract] [Full Text] [Related]
6. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
Camoglio C; Balla J; Fadda P; Dedoni S
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of the FRET-based Teen sensor to monitor erk activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor.
Fasano G; Petrini S; Bonavolontà V; Paradisi G; Pedalino C; Tartaglia M; Lauri A
Mol Med; 2024 Apr; 30(1):47. PubMed ID: 38594640
[TBL] [Abstract] [Full Text] [Related]
8. Dachshund Homolog 1: Unveiling Its Potential Role in Megakaryopoiesis and
Lin GL; Chang HH; Lin WT; Liou YS; Lai YL; Hsieh MH; Chen PK; Liao CY; Tsai CC; Wang TF; Chu SC; Kau JH; Huang HH; Hsu HL; Sun DS
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542074
[TBL] [Abstract] [Full Text] [Related]
9. LSP1 promotes the progression of acute myelogenous leukemia by regulating KSR/erk signaling pathway and cell migration.
Li T; Gui X; Li B; Hu X; Wang Y
Hematology; 2024 Dec; 29(1):2330285. PubMed ID: 38511641
[TBL] [Abstract] [Full Text] [Related]
10. Azacitidine-Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human leukemia Cells.
Lai KM; Tseng RH; Shih YH; Huang YC
Anticancer Res; 2024 Mar; 44(3):1033-1044. PubMed ID: 38423637
[TBL] [Abstract] [Full Text] [Related]
11. AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis.
Oskouian B; Lee JY; Asgharzadeh S; Khan R; Zhang M; Weisbrod JR; Choi YJ; Puri L; Aguilar AE; Zhao P; Saba JD
Oncogene; 2024 Apr; 43(16):1203-1213. PubMed ID: 38413795
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations.
Wang Z; Lu X; Liu C; Huang F; Lu T; Chen Y; Liu L; Lu S
Eur J Med Chem; 2024 Mar; 268():116237. PubMed ID: 38387337
[TBL] [Abstract] [Full Text] [Related]
13. Design, Synthesis, and Molecular Docking of Novel Miscellaneous Chalcones as p38α Mitogen-Activated Protein Kinase Inhibitors.
Zeid MM; El-Badry OM; Elmeligie S; Hassan RA
Chem Biodivers; 2024 Apr; 21(4):e202400077. PubMed ID: 38359316
[TBL] [Abstract] [Full Text] [Related]
14. Licochalcone A induces mitochondria-dependent apoptosis and interacts with venetoclax in acute myeloid leukemia.
Li Y; Zhao M; Lin Y; Jiang X; Jin L; Ye P; Lu Y; Pei R; Jiang L
Eur J Pharmacol; 2024 Apr; 968():176418. PubMed ID: 38350590
[TBL] [Abstract] [Full Text] [Related]
15. IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation.
Yang J; Chen J; Chang J; Sun X; Wei Q; Cai X; Cao P
Cell Commun Signal; 2024 Feb; 22(1):116. PubMed ID: 38347540
[TBL] [Abstract] [Full Text] [Related]
16. CircRNAome of Childhood Acute Lymphoblastic leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in
Gutierrez-Camino A; Caron M; Richer C; Fuchs C; Illarregi U; Poncelet L; St-Onge P; Bataille AR; Tremblay-Dauphinais P; Lopez-Lopez E; Camos M; Ramirez-Orellana M; Astigarraga I; Lécuyer É; Bourque G; Martin-Guerrero I; Sinnett D
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338754
[TBL] [Abstract] [Full Text] [Related]
17. Pharmaco-phosphoproteomic analysis of cancer-associated KIT mutations D816V and V560G.
Murray HC; Miller K; Dun MD; Verrills NM
Proteomics; 2024 May; 24(9):e2300309. PubMed ID: 38334196
[TBL] [Abstract] [Full Text] [Related]
18. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
[TBL] [Abstract] [Full Text] [Related]
19. Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or erk1/STAT3/MYC pathways.
Teng CJ; Cheng PT; Cheng YC; Tsai JR; Chen MC; Lin H
Toxicol In Vitro; 2024 Apr; 96():105768. PubMed ID: 38135130
[TBL] [Abstract] [Full Text] [Related]
20. Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3.
Shi Y; Yuan Q; Chen Y; Li X; Zhou Y; Zhou H; Peng F; Jiang Y; Qiao Y; Zhao J; Zhang C; Wang J; Liu K; Dong Z
Phytomedicine; 2024 Jan; 123():155235. PubMed ID: 38128397
[TBL] [Abstract] [Full Text] [Related]
[Next]
